Pharmacological modifications of the 6-hydroxy-dopa induced degeneration of central noradrenaline neurons.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000187:drug effects; D002421:Caudate Nucleus / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D002845:Chromatography; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D009410:Nerve Degeneration / Q000187:drug effects*; D009474:Neurons / Q000502:physiology; D009638:Norepinephrine / Q000378:metabolism / Q000502:physiology*; D014316:Tritium
D014316:Tritium; D004295:Dihydroxyphenylalanine; D000661:Amphetamine; D004298:Dopamine; D009638:Norepinephrine